C. Evan Ballantyne
2012 - Synthetic Biologics
In 2012, C. Evan Ballantyne earned a total compensation of $1.4M as Chief Financial Officer at Synthetic Biologics.
Compensation breakdown
| Bonus | $44,000 |
|---|---|
| Option Awards | $1,044,000 |
| Salary | $267,000 |
| Other | $7,000 |
| Total | $1,362,000 |
Ballantyne received $1M in option awards, accounting for 77% of the total pay in 2012.
Ballantyne also received $44K in bonus, $267K in salary and $7K in other compensation.
Rankings
In 2012, C. Evan Ballantyne's compensation ranked 4,923rd out of 11,487 executives tracked by ExecPay. In other words, Ballantyne earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,923 out of 11,487 | 57th |
Division Manufacturing | 1,723 out of 4,253 | 60th |
Major group Chemicals And Allied Products | 409 out of 1,198 | 66th |
Industry group Drugs | 263 out of 920 | 71st |
Industry Pharmaceutical Preparations | 207 out of 700 | 70th |
Source: SEC filing on April 13, 2015.
Ballantyne's colleagues
We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2012.
2012
Jeffrey Riley
Synthetic Biologics